Effect of Testosterone Suppression on the Pharmacokinetics of a Potent GnRH Receptor Antagonist

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2002 Mar 9

PMID 11883648

Citations 2

Authors

Eugenia A Iatsimirskaia

Margaret L Gregory

Kenna L Anderes

Rosemary Castillo

K Eric Milgram

David R Luthin

Ved P Pathak

Lance C Christie

Haresh Vazir

Mark B Anderson

John M May

Affiliations

Soon will be listed here.

Abstract

Purpose: The expression of cytochrome P450 enzymes (CYPs) in animals and humans is under complex hormonal regulation. Chronic treatment with drugs that alter sex hormone levels such as GnRH receptor agonists or antagonists may affect the expression of hormone-dependent CYPs, and as a result the pharmacokinetics of drugs metabolized by them.

Methods: Enzyme kinetic parameters were obtained by incubating AG-045572 (0.1-30 microM) with human or rat liver microsomes, or expressed CYP3A4 and CYP3A5. The pharmacokinetics of AG-045572 (10 mg/kg i.v. or 20 mg/kg p.o.) were studied in intact male, female, castrated male and male rats pretreated with AG-045572 for 4 days.

Results: AG-045572 is metabolized by CYP3A in both rats and humans. The Km values were similar in male and female human, female rat liver microsomes, and expressed CYP3A4 and CYP3A5 (0.39, 0.27, 0.28, 0.25, and 0.26 microM, respectively). The Km in male rat liver microsomes was 1.5 microM, suggesting that in male and female rats AG-045572 is metabolized by different CYP3A isozymes. The oral bioavailability of AG-045572 in intact male rats was 8%, while in female or castrated male rats it was 24%. Pretreatment of intact male rats with AG-045572 i.m. for 4 days resulted in suppression of testosterone to castrate levels, accompanied by an increase in oral bioavailability of AG-045572 to 27%. In the same experiment, the male-specific pulsatile pattern of growth hormone remained unchanged with slightly elevated baseline levels.

Conclusions: The potent GnRH receptor antagonist AG-045572 is metabolized by hormone-dependent CYP3A. As a result, suppression of testosterone by pretreatment with AG-045572 "feminized" its own pharmacokinetics.

Citing Articles

Small molecule piperazinyl-benzimidazole antagonists of the gonadotropin-releasing hormone (GnRH) receptor.

Fjellaksel R, Boomgaren M, Sundset R, Haraldsen I, Hansen J, Riss P Medchemcomm. 2018; 8(10):1965-1969.

PMID: 30108717 PMC: 6072469. DOI: 10.1039/c7md00320j.

Effect of gonadectomy and hormones on sex differences in ketoprofen enantiomer glucuronidation and renal excretion of formed glucuronides in the rat.

Palylyk-Colwell E, Jamali F Pharm Res. 2004; 21(6):989-95.

PMID: 15212164 DOI: 10.1023/b:pham.0000029288.48673.c2.

References

Lund J, Zaphiropoulos P, Mode A, Warner M, Gustafsson J . Hormonal regulation of cytochrome P-450 gene expression. Adv Pharmacol. 1991; 22:325-54. DOI: 10.1016/s1054-3589(08)60040-x. View

Harms P, Ojeda S . A rapid and simple procedure for chronic cannulation of the rat jugular vein. J Appl Physiol. 1974; 36(3):391-2. DOI: 10.1152/jappl.1974.36.3.391. View

Chen G, Ronis M, Ingelman-Sundberg M, Badger T . Hormonal regulation of microsomal cytochrome P4502E1 and P450 reductase in rat liver and kidney. Xenobiotica. 1999; 29(5):437-51. DOI: 10.1080/004982599238461. View

Agrawal A, Shapiro B . Gender, age and dose effects of neonatally administered aspartate on the sexually dimorphic plasma growth hormone profiles regulating expression of the rat sex-dependent hepatic CYP isoforms. Drug Metab Dispos. 1997; 25(11):1249-56. View

Waxman D, Ram P, NOTANI G, Leblanc G, Alberta J, Morrissey J . Pituitary regulation of the male-specific steroid 6 beta-hydroxylase P-450 2a (gene product IIIA2) in adult rat liver. Suppressive influence of growth hormone and thyroxine acting at a pretranslational leve;. Mol Endocrinol. 1990; 4(3):447-54. DOI: 10.1210/mend-4-3-447. View

Wang H, Strobel H . Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Arch Biochem Biophys. 1997; 344(2):365-72. DOI: 10.1006/abbi.1997.0230. View

Jansson J, Eden S, Isaksson O . Sexual dimorphism in the control of growth hormone secretion. Endocr Rev. 1985; 6(2):128-50. DOI: 10.1210/edrv-6-2-128. View

Ribeiro V, Lechner M . Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys. 1992; 293(1):147-52. DOI: 10.1016/0003-9861(92)90377-9. View

Ram P, Waxman D . Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Mol Endocrinol. 1991; 5(1):13-20. DOI: 10.1210/mend-5-1-13. View

10.

Waxman D, Ram P, Pampori N, Shapiro B . Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol. 1995; 48(5):790-7. View

11.

Rebbeck T, Jaffe J, Walker A, Wein A, Malkowicz S . Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst. 1998; 90(16):1225-9. DOI: 10.1093/jnci/90.16.1225. View

12.

DeVita R, Hollings D, Goulet M, Wyvratt M, Fisher M, Lo J . Identification and initial structure-activity relationships of a novel non-peptide quinolone GnRH receptor antagonist. Bioorg Med Chem Lett. 1999; 9(17):2615-20. DOI: 10.1016/s0960-894x(99)00446-1. View

13.

Kato R, Yamazoe Y . Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett. 1992; 64-65 Spec No:661-7. DOI: 10.1016/0378-4274(92)90245-f. View

14.

Mahnke A, Strotkamp D, Roos P, Hanstein W, Chabot G, Nef P . Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys. 1997; 337(1):62-8. DOI: 10.1006/abbi.1996.9752. View

15.

Agrawal A, Shapiro B . Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J Pharmacol Exp Ther. 1999; 292(1):228-37. View

16.

Pampori N, Shapiro B . Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology. 1999; 140(3):1245-54. DOI: 10.1210/endo.140.3.6545. View

17.

Oinonen T, Lindros K . Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. Biochem J. 1995; 309 ( Pt 1):55-61. PMC: 1135799. DOI: 10.1042/bj3090055. View

18.

Jansson J, Ekberg S, Isaksson O, Eden S . Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat. Endocrinology. 1984; 114(4):1287-94. DOI: 10.1210/endo-114-4-1287. View

19.

Liddle C, Goodwin B, George J, Tapner M, Farrell G . Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab. 1998; 83(7):2411-6. DOI: 10.1210/jcem.83.7.4877. View

20.

McClure M, Stupans I . Hormonal perturbation as a possible mechanism for the alteration of cytochrome P450 by cyclophosphamide. Biochem Pharmacol. 1995; 49(12):1827-36. DOI: 10.1016/0006-2952(94)00522-n. View